Why the study?
Does transthoracic echocardiography with additional abdominal aorta evaluation detect abdominal aortic aneurysms as effectively as abdominal ultrasonography?
Does transthoracic echocardiography with additional abdominal aorta evaluation detect abdominal aortic aneurysms as effectively as abdominal ultrasonography?
Routine transthoracic echocardiography with an added view of the abdominal aorta is as effective as dedicated abdominal ultrasonography for detecting abdominal aortic aneurysms.
Answers are grounded in this paper and cite their sources.
Similar AAA detection by TTE versus AUS should not yet change practice; leaves open prospective validation of screening utility.
INTRODUCTION: We previously reported that the prevalence of abdominal aortic aneurysms (AAAs) was higher in patients undergoing scheduled transthoracic echocardiography (TTE) than in patients undergoing abdominal ultrasonography (AUS); however, intergroup patient backgrounds differed significantly in that report. PURPOSE: We tested the hypothesis that TTE could detect AAA as effectively as AUS. DESIGN: A propensity score-matching analysis of a cross-sectional study was adopted as the design for this study. METHODS: We enrolled 7,619 and 15,433 patients scheduled to undergo TTE with additional evaluation of abdominal aorta at the end of the routine study and AUS, respectively, from 2009 to 2010 in our hospital, as reported. A propensity score for profiles of patients who underwent TTE or AUS was developed to adjust for potential confounding bias. Consequently, 4,388 patients in each group were matched for analyses. RESULTS: In propensity-matched patients, AAA was detected in 59 patients of the TTE group and in 48 patients of the AUS group; the prevalence of AAA detection did not differ significantly between TTE and AUS groups (P = 0.331). Positive associations were observed between AAA detection and male sex (adjusted odds ratio [OR]: 3.25; 95% confidence interval [CI], 2.05-5.15; P < 0.001), older age (adjusted OR: 1.029; 95% CI: 1.01-1.04; P < 0.001), and the presence of ischemic heart disease (adjusted OR: 1.78; 95% CI: 1.04-3.03; P = 0.033) and hypertension (adjusted OR: 2.16; 95% CI: 1.38-3.37; P = 001). CONCLUSION: TTE detected AAA with comparable efficacy as AUS in propensity-matched groups who underwent scheduled TTE and AUS.
No takes yet. Share an insight, caveat, or question.
Kato et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: